Invesco Biotechnology & Genome ETF (PBE) Chart & Stock Price History → CEO of Biggest AI Chipmaker Just Dropped a Bombshell… (From Banyan Hill Publishing) (Ad) Free PBE Stock Alerts $64.60 -0.42 (-0.65%) (As of 05/17/2024 ET) Add Compare Share Share ChartStock AnalysisChartHeadlinesHoldingsOwnershipRatingsStock AnalysisChartHeadlinesHoldingsOwnershipRatings Invesco Biotechnology & Genome ETF Stock Price Performance5 Day Performance+0.89%1 Month Performance+8.35%3 Month Performance-0.07%6 Month Performance+14.80%Year-To-Date Performance-1.89%1 Year Performance+4.83% Receive PBE Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Invesco Biotechnology & Genome ETF and its competitors with MarketBeat's FREE daily newsletter Email Address Ad InvestorPlaceBreaking News: Elon Musk Invents New Type of A.I. (Shocking)Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street veteran, Eric Fry… This mind-blowing new technology could be bigger than the iPhone.Click here for the full story… PBE Stock Chart for Saturday, May, 18, 2024 PBE Chart by TradingView Invesco Biotechnology & Genome ETF Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/17/2024$65.01$64.60-0.63%$64.95$64.494,689 shs$260.98 million05/16/2024$65.42$65.01-0.63%$65.11$64.883,569 shs$262.64 million05/15/2024$64.61$65.42+1.25%$65.65$65.263,513 shs$264.30 million05/14/2024$64.03$64.61+0.91%$64.61$64.288,479 shs$244.87 million05/13/2024$63.58$64.03+0.71%$64.13$63.852,227 shs$242.67 million05/10/2024$64.07$63.58-0.77%$64.27$63.453,736 shs$240.97 million Get the Latest News and Ratings for PBE and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Invesco Biotechnology & Genome ETF and its competitors with MarketBeat's FREE daily newsletter. 05/09/2024$63.75$64.07+0.50%$64.16$63.343,115 shs$242.83 million05/08/2024$64.15$63.75-0.63%$64.29$63.646,145 shs$241.61 million05/07/2024$63.54$64.15+0.97%$64.24$63.449,232 shs$243.14 million05/06/2024$64.06$63.54-0.81%$63.88$63.404,887 shs$240.81 million05/03/2024$63.56$64.06+0.79%$64.89$64.0615,714 shs$242.79 million05/02/2024$62.86$63.56+1.11%$63.76$63.088,559 shs$240.89 million05/01/2024$60.87$62.86+3.27%$63.52$62.159,215 shs$238.24 million04/30/2024$61.44$60.87-0.92%$61.40$60.8720,318 shs$230.71 million04/29/2024$60.39$61.44+1.73%$61.78$61.364,776 shs$232.84 million04/26/2024$59.85$60.39+0.90%$60.62$59.896,904 shs$229.47 million04/25/2024$60.88$59.85-1.69%$60.05$59.476,199 shs$227.43 million04/24/2024$61.15$60.88-0.44%$61.41$60.795,327 shs$231.34 million04/23/2024$60.40$61.15+1.23%$61.65$61.00245,003 shs$232.36 million04/22/2024$59.85$60.40+0.93%$60.85$60.094,887 shs$229.53 million04/19/2024$59.62$59.85+0.39%$60.04$59.325,281 shs$227.43 million04/18/2024$60.56$59.62-1.55%$60.51$59.608,056 shs$226.56 million04/17/2024$60.74$60.56-0.30%$60.92$60.565,522 shs$230.13 million04/16/2024$60.71$60.74+0.05%$61.09$60.743,706 shs$230.81 million04/15/2024$61.33$60.71-1.00%$61.46$60.6512,374 shs$230.70 million04/12/2024$62.67$61.33-2.15%$62.40$61.081,975 shs$233.04 million04/11/2024$62.65$62.67+0.03%$62.79$62.452,059 shs$238.15 million04/10/2024$63.61$62.65-1.51%$62.65$62.423,188 shs$248.73 million04/09/2024$62.97$63.61+1.02%$63.61$63.322,544 shs$252.53 million04/08/2024$62.83$62.97+0.22%$63.10$62.704,524 shs$249.99 million04/05/2024$62.57$62.77+0.33%$63.17$61.8912,139 shs$249.20 million04/04/2024$63.28$62.57-1.13%$63.81$62.572,353 shs$248.39 million04/03/2024$63.08$63.28+0.32%$63.44$62.9014,710 shs$251.22 million04/02/2024$64.47$63.08-2.16%$63.64$63.062,797 shs$250.43 million04/01/2024$64.72$64.47-0.38%$64.47$63.903,334 shs$255.95 million03/29/2024$64.72$64.72$65.20$64.723,967 shs$256.92 million03/28/2024$65.14$64.72-0.64%$65.20$64.723,967 shs$256.92 million03/27/2024$64.51$65.14+0.97%$65.15$64.468,546 shs$258.59 million03/26/2024$64.68$64.51-0.26%$64.91$64.498,606 shs$256.11 million03/25/2024$64.88$64.68-0.30%$64.87$64.574,148 shs$256.78 millionDems have chosen Biden replacement? (Ad)On November 16, 2023… Joe Biden accidentally revealed the name of the candidate… Who will replace him in the 2024 presidential election.See who it is HERE.03/22/2024$65.18$64.88-0.46%$65.25$64.765,078 shs$257.57 million03/21/2024$64.94$65.18+0.37%$65.46$65.1815,792 shs$258.77 million03/20/2024$64.59$64.94+0.55%$64.94$63.943,680 shs$257.81 million03/19/2024$64.02$64.59+0.88%$64.71$63.815,412 shs$256.41 million03/18/2024$64.07$64.02-0.08%$64.50$63.804,962 shs$254.16 million03/15/2024$64.04$64.07+0.05%$64.37$64.002,458 shs$254.36 million03/14/2024$65.41$64.04-2.09%$64.78$63.727,532 shs$254.24 million03/13/2024$65.46$65.41-0.08%$65.94$65.198,001 shs$259.68 million03/12/2024$66.10$65.46-0.97%$65.72$65.2513,055 shs$259.88 million03/11/2024$66.88$66.10-1.16%$67.10$65.996,969 shs$262.42 million03/08/2024$66.78$66.87+0.13%$67.69$66.807,537 shs$265.47 million03/07/2024$66.23$66.78+0.83%$66.94$66.5070,420 shs$265.12 million03/06/2024$66.32$66.23-0.14%$66.75$66.11199,623 shs$262.93 million03/05/2024$66.74$66.32-0.62%$66.44$65.995,289 shs$263.30 million03/04/2024$67.29$66.74-0.82%$67.55$66.415,132 shs$264.96 million03/01/2024$65.56$67.29+2.64%$67.68$65.7218,312 shs$267.14 million02/29/2024$66.39$65.56-1.25%$67.03$65.563,567 shs$260.27 million02/28/2024$66.67$66.39-0.42%$66.95$66.334,717 shs$263.57 million02/27/2024$65.89$66.67+1.18%$66.78$65.757,643 shs$264.68 million02/26/2024$64.60$65.89+2.00%$65.92$64.4337,637 shs$261.58 million02/23/2024$63.99$64.60+0.95%$64.68$63.915,257 shs$256.46 million02/22/2024$63.59$63.99+0.63%$64.11$63.313,211 shs$254.04 million02/21/2024$64.06$63.59-0.73%$64.11$63.203,826 shs$252.45 million02/20/2024$64.64$64.06-0.90%$64.59$63.775,403 shs$254.32 million02/19/2024$64.64$64.640.00%$65.09$64.642,900 shs$256.62 million Related Companies: XHE Stock Chart PJP Stock Chart PSCH Stock Chart XPH Stock Chart CURE Stock Chart PTH Stock Chart PINK Stock Chart SBIO Stock Chart SURI Stock Chart LABD Stock Chart Receive PBE Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Invesco Biotechnology & Genome ETF and its competitors with MarketBeat's FREE daily newsletter. This page (NYSEARCA:PBE) was last updated on 5/18/2024 by MarketBeat.com Staff From Our PartnersDems have chosen Biden replacement?Paradigm PressCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingHe called Apple at $1.49 and now he says: “Buy these 6 AI stocks.”InvestorPlaceThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaWhat’s Really Next for America…Porter & CompanyExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersProtect Your Bank Account Before It’s Too LateWeiss RatingsPOTUS in ‘25 Not Biden/Trump, ButThe Freeport Society Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Invesco Biotechnology & Genome ETF Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.